Oncology

Content will be added shortly.

Sl No. Title Authors Journal Name Publication Year
1 miR-18a Activates Wnt Pathway in ER-positive Breast Cancer and Is Associated With Poor Prognosis Nair MG, Prabhu JS, Korlimarla A, Rajarajan S, Hari PS, Kaul R, Alexander A, Raghavan R, Srinath BS, Sridhar TS Cancer Med 2020
2 Expression of HER2 and EGFR Proteins in Advanced Stage High-grade Serous Ovarian Tumors Show Mutual Exclusivity Crasta J, Ravikumar G, Rajarajan S, Gali S, Kulkarni KA, Vallikad E, Prabhu J Int J Gynecol Pathol 2020
3 Progress in psycho-oncology with special reference to developing countries Murthy RS, Alexander A Curr Opin Psychiatry 2019
4 Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia Ganesan S, Palani HK, Lakshmanan V, Balasundaram N, Alex AA, David S, Venkatraman A, Korula A, George B, Balasubramanian P, Palakodeti D, Vyas N, Mathews V Cell Death Dis 2019
5 A smart tele-cytology point-of-care platform for oral cancer screening Sunny S, Baby A, James BL, Balaji D, N V A, Rana MH, Gurpur P, Skandarajah A, D'Ambrosio M, Ramanjinappa RD, Mohan SP, Raghavan N, Kandasarma U, N S, Raghavan S, Hedne N, Koch F, Fletcher DA, Selvam S, Kollegal M, N PB, Ladic L, Suresh A, Pandya HJ, Kuriakose MA PLoS One 2019
6 Cystic Neutrophilic Granulomatous Mastitis: A Clinicopathological Study With 16s rRNA Sequencing for the Detection of Corynebacteria in Formalin-Fixed Paraffin-Embedded Tissue Naik MA, Korlimarla A, Shetty ST, Fernandes AM, Pai SA Int J Surg Pathol 2019
7 RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target Thomas P, Pranatharthi A, Ross C, Srivastava S J Exp Clin Cancer Res 2019
8 RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer Pranatharthi A, Thomas P, Udayashankar AH, Bhavani C, Suresh SB, Krishna S, Thatte J, Srikantia N, Ross CR, Srivastava S J Exp Clin Cancer Res 2019
9 The impact of breast cancer on the patient and the family in Indian perspective Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS Indian J Palliat Care 2019
10 HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, CE Anupama, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS Tumour Biology 2017
11 Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS Translational Oncology 2017
12 Analysis of Clinico-Pathological Characteristics of Indian Breast CancersShows Conservation of Specific Features in the Hormone Receptor Sub-Types Mukherjee G, Lakshmaiah KC, Vijayakumar M, Prabhu JS, Telikicherla D, Sridhar TS, Kumar RV Journal of Integrative Oncology 2016
13 High expression of integrin beta6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS Cancer Medicine 2016
14 Beta3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Experimental Cell Research 2016
15 Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS Data in Brief 2016